Teladoc Health Income from Continuous Operations 2014-2025 | TDOC
Teladoc Health income from continuous operations from 2014 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Teladoc Health Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-1,001 |
| 2023 | $-220 |
| 2022 | $-13,660 |
| 2021 | $-429 |
| 2020 | $-485 |
| 2019 | $-99 |
| 2018 | $-97 |
| 2017 | $-107 |
| 2016 | $-74 |
| 2015 | $-58 |
| 2014 | $-17 |
| 2013 | $-6 |
| Teladoc Health Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-33 |
| 2025-03-31 | $-93 |
| 2024-12-31 | $-48 |
| 2024-09-30 | $-33 |
| 2024-06-30 | $-838 |
| 2024-03-31 | $-82 |
| 2023-12-31 | $-29 |
| 2023-09-30 | $-57 |
| 2023-06-30 | $-65 |
| 2023-03-31 | $-69 |
| 2022-12-31 | $-3,810 |
| 2022-09-30 | $-73 |
| 2022-06-30 | $-3,101 |
| 2022-03-31 | $-6,675 |
| 2021-12-31 | $-11 |
| 2021-09-30 | $-84 |
| 2021-06-30 | $-134 |
| 2021-03-31 | $-200 |
| 2020-12-31 | $-394 |
| 2020-09-30 | $-36 |
| 2020-06-30 | $-26 |
| 2020-03-31 | $-30 |
| 2019-12-31 | $-19 |
| 2019-09-30 | $-20 |
| 2019-06-30 | $-29 |
| 2019-03-31 | $-30 |
| 2018-12-31 | $-25 |
| 2018-09-30 | $-23 |
| 2018-06-30 | $-25 |
| 2018-03-31 | $-24 |
| 2017-12-31 | $-44 |
| 2017-09-30 | $-31 |
| 2017-06-30 | $-15 |
| 2017-03-31 | $-16 |
| 2016-12-31 | $-14 |
| 2016-09-30 | $-30 |
| 2016-06-30 | $-15 |
| 2016-03-31 | $-15 |
| 2015-12-31 | $-15 |
| 2015-09-30 | $-13 |
| 2015-06-30 | $-17 |
| 2015-03-31 | $-13 |
| 2014-12-31 | $-7 |
| 2014-09-30 | $-5 |
| 2014-06-30 | $-3 |
| 2014-03-31 | $-2 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.366B | $2.570B |
| Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.378B | 27.33 |
| CVS Health (CVS) | United States | $92.778B | 11.54 |
| Elevance Health (ELV) | United States | $71.753B | 9.65 |
| Cencora (COR) | United States | $56.537B | 18.83 |
| DiDi Global (DIDIY) | China | $27.533B | 22.50 |
| Labcorp Holdings (LH) | United States | $23.101B | 18.36 |
| Natera (NTRA) | United States | $23.092B | 0.00 |
| BioMerieux (BMXMF) | France | $16.600B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.580B | 0.00 |
| ICON (ICLR) | Ireland | $14.370B | 13.83 |
| Medpace Holdings (MEDP) | United States | $13.359B | 35.35 |
| CochLear (CHEOY) | Australia | $12.878B | 0.00 |
| Solventum (SOLV) | United States | $12.673B | 13.08 |
| Viatris (VTRS) | United States | $12.300B | 4.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.796B | 0.00 |
| Revvity (RVTY) | United States | $10.459B | 18.43 |
| Avantor (AVTR) | United States | $9.183B | 13.47 |
| Charles River Laboratories (CRL) | United States | $8.037B | 15.25 |
| Sonic Healthcare (SKHHY) | Australia | $7.750B | 0.00 |
| HealthEquity (HQY) | United States | $7.725B | 33.84 |
| Bausch + Lomb (BLCO) | Canada | $5.179B | 34.83 |
| Sotera Health (SHC) | United States | $4.650B | 25.98 |
| BrightSpring Health Services (BTSG) | United States | $4.197B | 32.01 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| GeneDx Holdings (WGS) | United States | $3.720B | 85.19 |
| Alignment Healthcare (ALHC) | United States | $3.240B | 0.00 |
| Concentras Parent (CON) | United States | $3.050B | 19.35 |
| Surgery Partners (SGRY) | United States | $2.909B | 36.60 |
| Organon (OGN) | United States | $2.449B | 2.67 |
| Premier (PINC) | United States | $2.138B | 19.77 |
| KindlyMD (NAKA) | United States | $2.046B | 0.00 |
| Progyny (PGNY) | United States | $2.035B | 43.04 |
| Ardent Health (ARDT) | United States | $1.816B | 7.01 |
| PACS (PACS) | United States | $1.774B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.511B | 25.59 |
| Pediatrix Medical (MD) | United States | $1.499B | 10.01 |
| Omada Health (OMDA) | $1.364B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.196B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.847B | 4.96 |
| AMN Healthcare Services Inc (AMN) | United States | $0.796B | 9.85 |
| CareDx (CDNA) | United States | $0.727B | 13.39 |
| Performant Healthcare (PHLT) | United States | $0.603B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
| Agilon Health (AGL) | United States | $0.530B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.517B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.488B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
| Nutex Health (NUTX) | United States | $0.465B | 7.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.424B | 0.00 |
| SBC Medicals (SBC) | United States | $0.424B | 9.27 |
| Enhabit (EHAB) | United States | $0.399B | 26.27 |
| So-Young (SY) | China | $0.390B | 0.00 |
| Oncology Institute (TOI) | United States | $0.318B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.264B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.173B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.066B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |